Literature DB >> 8741010

Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases.

N Volpe-Júnior1, E A Donadi, I F Carvalho, M L Reis.   

Abstract

We studied some of the components of the kininogen-kallikrein-kinin system, simultaneously, in plasma and synovial effusions of patients with inflammatory articular diseases. Plasma and tissue kallikrein like activity and kininogen levels were evaluated. Active plasma and tissue kallikreins in plasma and synovial fluid were detected by their amidase activity upon specific chromogenic substrates. Kininogen levels were determined by a bioassay. Both specific amidase activity of plasma and tissue kallikreins were augmented in synovial effusions in relation to their own plasma activity. Kininogen levels in synovial fluid tended to be diminished in relation to plasma, however statistical significance was not reached. The consumption of kininogen is probably related to kinin production. This finding together with increased activities of plasma and tissue kallikreins reinforce the involvement of kinins in pathogenesis of inflammatory articular diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8741010     DOI: 10.1007/bf02285161

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  17 in total

1.  A micromethod for determination of bradykininogen under several conditions.

Authors:  C R DINIZ; I F CARVALHO
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

Review 2.  Bioregulation of kinins: kallikreins, kininogens, and kininases.

Authors:  K D Bhoola; C D Figueroa; K Worthy
Journal:  Pharmacol Rev       Date:  1992-03       Impact factor: 25.468

3.  Raised plasma kininogen levels in rheumatoid patients-response to therapy with monsteroidal anti-inflammatory drugs.

Authors:  I J Zeitlin; J N Sharma; P M Brooks; W C Dick
Journal:  Adv Exp Med Biol       Date:  1976       Impact factor: 2.622

4.  Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein.

Authors:  C Kluft
Journal:  J Lab Clin Med       Date:  1978-01

5.  Kallikrein in synovial fluid with rheumatoid arthritis.

Authors:  M Suzuki; A Ito; Y Mori; Y Hayashi; K Matsuta
Journal:  Biochem Med Metab Biol       Date:  1987-04

6.  Detection of kallikrein-like activity in inflamed synovial tissue.

Authors:  J N Sharma; I J Zeitlin; S D Deodhar; W W Buchanan
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-04

7.  The action of aspirin on plasma kininogen and other plasma proteins in rheumatoid patients: relationship to disease activity.

Authors:  J N Sharma; I J Zeitlin; P M Brooks; W W Buchanan; W C Dick
Journal:  Clin Exp Pharmacol Physiol       Date:  1980-07       Impact factor: 2.557

8.  Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid.

Authors:  H Nagase; T E Cawston; M De Silva; A J Barrett
Journal:  Biochim Biophys Acta       Date:  1982-03-18

9.  A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis.

Authors:  B M Selwyn; C D Figueroa; E Fink; A Swan; P A Dieppe; K D Bhoola
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

10.  The significant reduction of high molecular weight-kininogen in synovial fluid of patients with active rheumatoid arthritis.

Authors:  K Sawai; S Niwa; M Katori
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

View more
  1 in total

1.  Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.

Authors:  B A Katz; B Liu; M Barnes; E B Springman
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.